Early Access — free while we kick the tires
EdgarHawk

Henderson Jane

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2026-01-06

Companies

Company Buys Sells Direction
Apogee Therapeutics, Inc. APGE 0 3 Net selling

Activity

January 2026
medium
Sell
8,000 shares
$609,146
Significance 5/10

CFO Jane Henderson sold 8,000 APGE shares in 3 transactions (Jan 2–6) for $609,145.60 total; stock near 52-week high at $78.25.

CFO Jane Henderson executed 3 separate sales totaling 8,000 shares for $609,145.60, reducing her holdings by 4.1% from 193,371 to 185,371 shares. The sales occurred across two trading days (Jan 2–6, 2026) with blended average execution price of $76.14, occurring as the stock trades near its 52-week high of $78.54 (currently at $78.25, -0.4% from that peak). APGE is unprofitable with -$65.0M net income over its most recent full fiscal year, a material headwind that typically constrains valuation multiples. Henderson's own cross-ticker track record shows 100.00% well-timed selling rate on her prior 2 open-market sales (avg 90d return -6.2%), though that pattern spans multiple tickers and provides limited predictive power for this specific trade. The timing proximity to the 52-week high warrants attention given the company's unprofitable operating profile.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access